Asthma Market Analysis, Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

July 20 12:38 2020
Asthma Market Analysis, Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

“Asthma – Market Insights, Epidemiology, and Market Forecast-2030”

(Albany, US) Delveinsight has launched a new report on “Asthma – Market Insights, Epidemiology, and Market Forecast-2030″.


DelveInsight’s “Asthma – Market Insights, Epidemiology, and Market Forecast-2030 report delivers an in-depth understanding of the Asthma, historical and forecasted epidemiology as well as the Asthma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Some of the Key facts:

  • The prevalence of environmental diseases, including asthma, is increasing worldwide, with an estimated 400 million people likely to suffer from asthma in 2025.
  • Adults are four times more likely to die from asthma than children.
  • North America dominated the market share in 2019.
  • In 2019, the market value stood at USD 18.08 billion.


Request for Free Sample Report:


Report key Highlights:

  • In the coming years, Asthma market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence Asthma R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition       
  • Major players are involved in developing therapies for Asthma. Launch of emerging therapies will significantly impact the Asthma market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Asthma
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities.


Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment”


Asthma is an inflammatory disease of the airways to the lungs. It makes breathing difficult and can make some physical activities challenging or even impossible.

Asthma symptoms occur when the lining of your airways swell and the muscles around them tighten. Mucus then fills the airways, further reducing the amount of air that can pass through.

These conditions can then bring on an asthma “attack,” the coughing and tightness in your chest that’s typical of asthma.


Request for Free Sample Report:


Some of the Companies Covered:

  • GlaxoSmithKline
  • Merck & Co.
  • AstraZeneca/MedImmune
  • Novartis
  • Roche/Genentech
  • Teva
  • Boehringer Ingelheim
  • Sunovion
  • Ono Pharmaceutical Co.
  • And Many Others


Drugs Covered:

  • Fluticasone furoate
  • Cinquil (reslizumab)
  • Bosatria (mepolizumab)
  • Lebrikizumab
  • Benralizumab
  • Dupilumab
  • Tralokinumab
  • And Many Others


Request for Free Sample Report:


Table of Contents:

1. Key Insights

2. Executive Summary of Asthma

3. Competitive Intelligence Analysis for Asthma

4. Asthma: Market Overview at a Glance

5. Asthma: Disease Background and Overview

6. Patient Journey

7. Asthma Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Asthma Treatment

11. Marketed Products

11.1. List of Marketed Products in the 7MM

11.2. Drug Name: Company Name

11.2.1. Product Description

11.2.2. Regulatory Milestones

11.2.3. Other Developmental Activities

11.2.4. Pivotal Clinical Trials

11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

12.1. Key Cross

12.2. Drug Name: Company Name

12.2.1. Product Description

12.2.2. Other Developmental Activities

12.2.3. Clinical Development

12.2.4. Safety and Efficacy

12.2.5. Product Profile

List to be continued in report

13. Asthma: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Asthma

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight


Request for Detailed TOC:




Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States